Background Because cardiovascular disease is the major cause of death in dialysis patients, the correlation between diastolic left ventricular (LV) dysfunction and arterial sclerosis, including thoracic aortic calcification, was studied in chronic hemodialysis (HD) patients.
ardiovascular disease is the major cause of death in patients with chronic kidney disease. 1, 2 Calcification of the coronary arteries and the aorta has been recently recognized as an important risk factor for cardiovascular disease in hemodialysis (HD) patients. 3, 4 Vascular calcification is very common in end-stage renal disease (ESRD), especially in HD patients. 5 The mechanisms of vascular calcification are hyperphosphatemia and elevated calcium (Ca) × phosphate product. 6, 7 Clinical studies have supported the association between vascular calcification and cardiac changes. 8 Diffuse calcification of the media of arterial vessels with no relation to atheromatosis is highly prevalent in ESRD patients. 9 Vascular calcification induces stiffening of the vessel wall and reduces vascular compliance, which has been found to be predictive of cardiovascular mortality. 8, 10 Reduction of large-artery stiffness (ie, of the aortic arch or abdominal aorta) increases cardiac afterload.
Diastolic dysfunction is a common sequel of arterial hypertension, which usually occurs early, even before systolic dysfunction manifests. Diastolic left ventricular (LV) dysfunction is induced by increased afterload in healthy hearts of rabbits and dogs. 11 Arterial stiffness and diastolic LV function are interrelated and both are impaired in patients with diabetes mellitus (DM), essential hypertension, or both. 12, 13 In HD patients, reduced large-artery stiffness may contribute to vascular calcification in the thoracic and abdominal aorta, independently of blood pressure (BP). Therefore, LV diastolic dysfunction may be associated with aortic calcification in HD patients.
The aim of the present study was to determine the possible interrelationship between diastolic LV dysfunction, evaluated by tissue Doppler imaging (TDI), and thoracic and abdominal aortic calcification in HD patients.
Methods

Study Population
The study subjects were 142 maintenance HD patients (73 men, 69 women) treated at the Dialysis Unit of Hidaka Hospital. HD was performed 3 times weekly (4 h/day). The dialysis potassium concentration was 2.0 mmol/L and the Ca concentration was 3.0 mmol/L. Blood was drawn before starting each dialysis session. Hypertension was defined as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg, or use of antihypertensive medication. DM was defined by World Health Organization (WHO) criteria. 14 Hyperlipidemia was defined as fasting serum total cholesterol ≥230 mg/dl, low-density lipoprotein-cholesterol ≥140 mg/dl, triglyceride ≥150 mg/dl, high-density lipoprotein-cholesterol (HDL-C) <40 mg/dl or use of lipid-lowering medication. The clinical characteristics of patients are shown in Table 1 . All measurements were performed after the dialysis session.
8-slice technique of an Aquilion TSX-101A (Toshiba, Tokyo, Japan). Slices of 1.25-mm thickness were acquired at each time point under the following conditions: 120-140 kVp, 85-150 mA, 500-ms exposure, and 0.5 s gantry rotation. The entire heart was covered in a single breathhold (20-30 s) . Quantification of the aortic calcification volume was performed by 3-D calcified lesion reconstitution from multi-slices of the aorta from the top of the arch to 5 cm along the longitudinal axis using the zio M900 QADRA work station (AMIN, Inc, Tokyo, Japan).
Cardiac Ultrasonography
The echocardiographic studies were performed by an experienced senior cardiosonographer using an Aplio XV (Toshiba) ultrasound imager equipped with a 2.2/4.4 MHz (harmonics) phased-array 3S transducer, under continuous electrocardiographic monitoring. The data were saved in the device's archive (digital archive, raw data) and the obtained images were recalled for calculation of the study parameters by the same interpreter, who was unaware of each patient's clinical status.
The 2-D guided M-mode echocardiographic study of the LV was performed in the parasternal long-axis view, and the LV end-systolic and end-diastolic dimensions, as well as the interventricular septum and posterior wall thicknesses, were measured as the mean of 5 consecutive cardiac cycles, in accordance with the recommendations of the American Society of Echo-cardiography. 15 LV mass was measured using the formula of Deveraux:
in which IVS is the interventricular septum thickness, LVEDD is the LV end-diastolic diameter, and PW is the posterior wall thickness. It was indexed for body surface area to estimate the LV mass index (LVMI). 16 Furthermore, the peak velocities of the E and A waves of the transmitral flow, the isovolumic relaxation time (the time period between the end of aortic flow on Doppler tracing and the beginning of mitral diastolic flow on Doppler tracing), as well as the deceleration time (DT) of the E wave (time elapsed between peak E velocity and the point where the extrapolated deceleration slope of the E velocity crosses the zero baseline) were measured. Each of these pulsed Doppler parameters was assessed in 5 consecutive cardiac cycles and the mean values were obtained.
TDI
The TDI program was set in pulsed-wave Doppler mode. Motion of the mitral annulus was recorded in the apical 4-chamber view. Sample volumes were positioned sequentially at the lateral and septal corners of the mitral annulus. Two major negative velocities were recorded with movement of the annulus toward the base of the heart during diastole, as follows: 1 during the early phase of diastolic myocardial velocity (E'). Pulse-wave Doppler examination of mitral inflow, as well as TDI of the lateral mitral annulus, was performed in each subject. [17] [18] [19] [20] In an attempt to provide a continuous variable that might estimate diastolic elastance (Ed), the ratio of the mitral inflow early diastolic filling velocity (E) to the mitral annular early diastolic velocity measured by tissue Doppler (E') was used as an estimation of mean left atrial pressure (E/E'). [21] [22] [23] Operant Ed was then estimated as E/E' divided by the volume of filling during diastole, assuming the absence of significant aortic regurgitation. The E' was used as a measure of the speed of LV relaxation, because E' has been shown to correlate inversely with the time constant of isovolumic relaxation and is considered relatively preload-independent. All measurements were made by the same examiner under blind conditions.
Assessment of Arterial PWV
PWV was measured using a volume-plethysmographic apparatus (Form/ABI; Omuron-Colin Co Ltd, Komaki, Aichi, Japan). Details of the methodology have been described elsewhere. 24 Occlusion and monitoring cuffs were placed snugly around both sides of the upper and lower extremities, with the patient in the supine position, then the pressure waveforms of the brachial and tibial arteries were recorded after 15 min of rest, using an automatic waveform analyzer. The validation of this method has been reported previously. 24 
Statistical Analysis
All results are presented as means ± SD. Univariate associations between AoACV or PWV and clinical parameters were assessed using linear regression. Multivariate linear regression was performed to determine the factors related to LV dysfunction. All variables with a p-value less than 0.1 in the univariate analysis were included in the multivariate regression model. Stepwise backward elimination was used, beginning with the variable with the highest p-value. All analyses were conducted using the SPBS software, version 9.51 (Comworks, Tokyo, Japan) and p-values less than 
Results
Baseline Characteristics of the HD Patients
Clinical parameters of the HD patients in the present study are summarized in Table 1 . The underlying diseases were type 2 DM in 75 patients and chronic glomerulonephritis without DM in 67. Their mean age was 64.2±11.1 years, and the mean duration of dialysis (dialysis vintage) was 7.7±7.0 years. Seventy-three patients (51%) were men, and 76 (53%) had diabetes. The mean value of AoACV was 6.4±7.3 cm 3 ; 8 patients did not have aortic arch calcification.
Relationships Between Diastolic LV Function and the Clinical Parameters
In an attempt to evaluate the reliability of the LV function measurements, the intra-observer variability was determined by having an observer repeat the measurements of the mitral annular velocities in the same datasets from 10 randomly selected subjects 1 month later and it was 3.2± 2.3% (range: 0-8.2). Inter-observer measurement variability was determined by having a second observer and the variability values were calculated as the absolute difference between the corresponding 2 measurements as a percent of mean (3.5±2.4%, range: 0.1-8.4). Univariate analysis was performed to examine the relationships between diastolic LV function and the clinical parameters ( Table 2) . The E/E' correlated positively with age (r=0.19, p=0.02), dialysis vintage (r=0.18, p=0.037), systolic BP (r=0.29, p=0.001), PWV (r=0.33, p=0.0002), AoACV (r=0.37, p<0.0001), and LVMI (r=0.19, p=0.036).
Relationships Between AoACV and the Clinical Parameters
To determine the intra-reader variability, randomly selected gated scans were re-read by the same observer at different time points from 5 days to 2 weeks apart. The 2 readings of the AoACV scores were highly correlated (r=0.98, p<0.001). Intra-reader variability with a small randomly selected subset of patients (n=20) was 22%. Univariate analysis was performed to examine the relationships between AoACV and clinical parameters. The AoACV value correlated positively with age (r=0.366, p<0.0001), intact parathyroid hormone (r=0.073, p=0.001) and E/E' (r=0.371, p<0.0001), and negatively with diastolic BP (r= -0.17, p=0.048). AoACV did not correlate with the serum levels of albumin, total cholesterol, triglyceride, and HDL-C, or body mass index (BMI).
Relationships Between Arterial Compliance and the Clinical Parameters
Two measurements for PWV were performed in each leg and the average value was used for the analysis. The coefficient of variation of the PWV was less than 5%. This method has been validated in patients with coronary artery disease. 24 Univariate analysis was performed to examine the relationships between arterial stiffness and clinical parameters. The PWV value correlated positively with age (r= 0.364, p<0.0001), systolic BP (r=0.44, p<0.0001), diastolic BP (r=0.27, p=0.0017) and E/E' (r=0.313, p=0.0005), and negatively with albumin (r=0.050, p=0.011). PWV did not correlate with the serum levels of intact parathyroid hormone, total cholesterol, triglyceride, and HDL-C, or BMI.
Assessment of the Factors Related to Diastolic LV Dysfunction
Univariate and multivariate analyses were performed to investigate the factors related to diastolic LV dysfunction. E/E' values correlated positively with age (r=0.19, p=0.02), dialysis vintage (r=0.18, p=0.037), systolic BP (r=0.29, p= 0.0012), AoACV (r=0.37, p<0.0001, Fig 1) , PWV (r=0.33, p=0.0002, Fig 2) and LVMI (r=0.18, p=0.036, Fig 3) . Univariate analysis revealed no correlation between the ejection fraction and the clinical parameters or AoACV. Multiple Table 2 Correlation Between E/E' Related Parameters Abbreviations see in Table 1 . regression analysis showed that AoACV (coefficient = 0.26, p=0.005) and PWV (coefficient =0.22, p=0.03) were significant independent determinants of E/E' ( Table 3) . The clinical parameters of the serum levels of intact parathyroid hormone and phosphorus, LVMI, ejection fraction and systolic BP were not independently associated with diastolic LV dysfunction.
Discussion
Even though our observational study was limited by its cross-sectional design, the results indicate that diastolic LV dysfunction is associated with aortic calcification and arterial stiffness in maintenance HD patients. There are previous reports of relationships between diastolic LV function and hypertension, LV hypertrophy, and coronary artery disease. Our current results suggest that afterload, such as that caused by arterial stiffness or aortic calcification, may be a crucial factor not just in LV hypertrophy and coronary artery disease, but also diastolic LV dysfunction.
Rather than being associated with purely functional arterial stiffness, reduced diastolic function may involve the crucial factor of aortic calcification, and calcification of the aortic arch in particular. E/A and DT did not correlate with either AoACV or aortic calcification index (ACI), but this is thought to be attributed to E/A and DT following a pseudonormalized pattern in the course of diastolic LV dysfunction. 25, 26 In addition, diastolic LV dysfunction, similar to that in the hypertensive group, was observed in both the dialysis patients and in the normotensive group and did not differ from that in the hypertensive group. This finding indicates that cardiac diastolic LV function may be reduced in dialysis patients even if their BP is adequately controlled. Such functional loss may involve calcification of the aorta, and an association with calcification of the aortic arch in particular has been suggested.
Vascular calcification is now recognized as an active process involving a complex interaction of inducers and inhibitors. 27 Various factors may potentially exert marked influences on the predisposition, initiation and continuation phases of this process. Our multivariate analysis indicated that aortic calcification was associated with LV dysfunction in the study patients. There are previous reports of relationships between diastolic LV function and hypertension, LV hypertrophy, and coronary artery disease. 4, 5, 28, 29 Taken together, increased arterial compliance or aortic calcification may be associated with LV hypertrophy and diastolic LV dysfunction.
PWV has been shown to be a powerful noninvasive tool for assessing cardiovascular risk in dialysis patients. 30 Arterial stiffness is dependent on several risk factors such as aging and atherosclerosis. 31 Additional mechanisms may be responsible for the increased PWV in dialysis patients, namely extensive calcification in the vessel walls. This extensive calcification is caused by both heavily calcified atherosclerotic plaques 32 and calcification of the smooth muscle layers comprising the vessel wall. 8 We previously explored the significant correlation between PWV and the ACI as a determinant of LV hypertrophy in dialysis patients, 28 and Raggi et al recently reported an association between PWV and vascular calcification. 33 These findings suggest that aortic PWV is a marker for the development of atherosclerotic lesions in the vessel walls of HD patients, as in the general population. 34 In the current study, PWV was shown to be significantly associated with E/E' in dialysis patients, suggesting that increased arterial stiffness and aortic calcification are associated with diastolic LV dysfunction in these patients.
Study Limitations
The study was observational; however, quantification of AoACV was performed by 3-D calcified lesion reconstitution from multi slices of the aorta from the top of the arch to 5 cm along the longitudinal axis. Also, individual investigators reported the AoACV, PWV and LVMI measurements independently without knowledge of the results of other tests. We checked the prescribed medications in all patients studied, as shown in Table 1 . However, we found no relationships between medications and any of the results for E/E', PWV, LVMI and AoACV.
In conclusion, these results suggest that diastolic LV dysfunction may be associated with increased aortic calcification and reduced arterial stiffness in chronic HD patients. 
